We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ferring Overstates Efficacy for Cancer Drug: FDA
Ferring Overstates Efficacy for Cancer Drug: FDA
October 3, 2012
Ferring Pharmaceuticals has been handed an FDA untitled letter for overstating the efficacy and indication of its injectable prostate cancer drug Firmagon in a recent sales aid.